These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27790617)

  • 1. Prediction of the Carcinogenic Potential of Human Pharmaceuticals Using Repeated Dose Toxicity Data and Their Pharmacological Properties.
    van der Laan JW; Buitenhuis WH; Wagenaar L; Soffers AE; van Someren EP; Krul CA; Woutersen RA
    Front Med (Lausanne); 2016; 3():45. PubMed ID: 27790617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of carcinogenic potential of chemicals using repeated-dose (13-week) toxicity data.
    Woutersen RA; Soffers AE; Kroese ED; Krul CA; van der Laan JW; van Benthem J; Luijten M
    Regul Toxicol Pharmacol; 2016 Nov; 81():242-249. PubMed ID: 27614137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.
    van der Laan JW; Kasper P; Silva Lima B; Jones DR; Pasanen M
    Crit Rev Toxicol; 2016 Aug; 46(7):587-614. PubMed ID: 27116466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of carcinogenicity predictors from short-term and sub chronic repeat-dose studies of agrochemicals in rats: Opportunities to refine and reduce animal use.
    Mistry P; McInnes EF; Beevers C; Wolf D; Currie RA; Salimraj R; Parsons P
    Toxicol Lett; 2021 Oct; 351():18-27. PubMed ID: 34364947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of chronic 6- and 12-month rat toxicology studies as predictors of 2-year tumor outcome.
    Reddy MV; Sistare FD; Christensen JS; Deluca JG; Wollenberg GK; Degeorge JJ
    Vet Pathol; 2010 Jul; 47(4):614-29. PubMed ID: 20516294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans.
    Ennever FK; Noonan TJ; Rosenkranz HS
    Mutagenesis; 1987 Mar; 2(2):73-8. PubMed ID: 3331705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines.
    Sistare FD; Morton D; Alden C; Christensen J; Keller D; Jonghe SD; Storer RD; Reddy MV; Kraynak A; Trela B; Bienvenu JG; Bjurström S; Bosmans V; Brewster D; Colman K; Dominick M; Evans J; Hailey JR; Kinter L; Liu M; Mahrt C; Marien D; Myer J; Perry R; Potenta D; Roth A; Sherratt P; Singer T; Slim R; Soper K; Fransson-Steen R; Stoltz J; Turner O; Turnquist S; van Heerden M; Woicke J; DeGeorge JJ
    Toxicol Pathol; 2011 Jun; 39(4):716-44. PubMed ID: 21666103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Prospect Theory in Obstetrics by Evaluating Mode of Delivery and Outcomes in Neonates Born Small or Appropriate for Gestational Age.
    Michaeli J; Michaeli O; Rozitzky A; Grisaru-Granovsky S; Feldman N; Srebnik N
    JAMA Netw Open; 2022 Mar; 5(3):e222177. PubMed ID: 35289859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
    Brambilla G; Martelli A
    Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
    Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
    Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens.
    Chapman KE; Shah UK; Fletcher JF; Johnson GE; Doak SH; Jenkins GJS
    Mutagenesis; 2024 Mar; 39(2):69-77. PubMed ID: 38301659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.